NewsRoom

The SURVIVEiT® NewsRoom provides patients with quick access to exclusive news, treatment breakthroughs, survivor stories, and expert interviews providing the latest insight about this rapidly evolving industry. Visit our NewsRoom often and follow us on Facebook.

Category: Lung Cancer

FDA grants accelerated approval to lurbinectedin for metastatic small cell lung cancer

June 16th, 2020
Read More
A Cancer Patient’s Experience With Immunotherapy

June 10th, 2020
Read More
FDA grants accelerated approval to capmatinib for metastatic non-small cell lung cancer

June 2nd, 2020
Read More
FDA approves nivolumab plus ipilimumab for first-line mNSCLC (PD-L1 tumor expression ≥1%)

June 2nd, 2020
Read More
FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high PD-L1 expression

June 2nd, 2020
Read More
FDA approves brigatinib for ALK-positive metastatic NSCLC

June 2nd, 2020
Read More
FDA approves nivolumab plus ipilimumab and chemotherapy for first-line treatment of metastatic NSCLC

June 2nd, 2020
Read More
FDA approves ramucirumab plus erlotinib for first-line metastatic NSCLC

June 2nd, 2020
Read More
FDA approves durvalumab for extensive-stage small cell lung cancer

March 30th, 2020
Read More
5-Year Study Finds Treatment To Improve Overall Survival In Advanced NSCLC

November 2nd, 2019
Read More
3 Studies Show No Association Between Tumor Mutational Burden and Key Outcomes in NSCLC

September 18th, 2019
Read More
FDA approves entrectinib for NTRK solid tumors and ROS-1 NSCLC

August 19th, 2019
Read More
FDA approves pembrolizumab for metastatic small cell lung cancer

June 28th, 2019
Read More
FDA expands pembrolizumab indication for first-line treatment of NSCLC

April 23rd, 2019
Read More
FDA Approves Lorlatinib for ALK+ NSCLC

November 5th, 2018
Read More
World Lung 2018 – Alunbrig squares up to Xalkori, but the field is getting crowded

September 28th, 2018
Read More
First-line brigatinib improves PFS for ALK-positive non-small cell lung cancer

September 28th, 2018
Read More
FDA approves dacomitinib for metastatic non-small cell lung cancer

September 28th, 2018
Read More
Takeda Receives Positive CHMP Opinion Recommending (brigatinib) for Treatment of ALK+ NSCLC ...

September 24th, 2018
Read More
FDA grants approval for 1st line treatment of metastatic nonsquamous NSCLC

August 20th, 2018
Read More
FDA grants accelerated approval for 3rd line treatment of metastatic small cell lung cancer

August 20th, 2018
Read More
#WorldLungCancerDay - Take Action!

August 1st, 2018
Read More
TECENTRIQ (+chemo)...Helped People with Previously-Untreated Extensive-Stage Small Cell Lung Cancer

June 26th, 2018
Read More
The ‘Ross-Wonders’, Cancer’s New Superheroes

May 15th, 2018
Read More
FDA Approves TAGRISSO® As 1st-Line Treatment For EGFR-Mutated Non-Small Cell Lung Cancer

April 20th, 2018
Read More
FDA approves Imfinzi for NSC Lung Cancer patients.

February 19th, 2018
Read More
FDA Expands Afatinib’s Approval for Lung Cancer

January 15th, 2018
Read More
LIVE Webinar: What Are the Best Actionable Resources Available for Lung Cancer Patients?

November 15th, 2017
Read More
FDA Approves Genentech’s Alecensa (Alectinib) as First-Line Treatment for People with Specific Type

November 8th, 2017
Read More
Guardant Health Database Reveals Potential of Targeted Therapy Combinations to Treat Advanced LC

November 8th, 2017
Read More
New Trial for some NTRK, ALK and ROS1 patients.

October 30th, 2017
Read More
5 Facts You Probably Didn’t Know About Your Lungs

September 28th, 2017
Read More
LIVE Webinar: What’s the Hope Today for Living With Small Cell Lung Cancer? - Oct. 11, 2017

September 28th, 2017
Read More
Interpace Diagnostics : Announces Expansion into New Clinical Area with Launch of Molecular Lung Can

September 26th, 2017
Read More
FDA approves first biosimilar for the treatment of cancer

September 15th, 2017
Read More
Tagrisso significantly improves progression-free survival in… trial for lung cancer

September 6th, 2017
Read More
FDA Okays WIN Consortium Trial to Test Three-Drug NSCLC Combo; Validate SIMS Algorithm

August 29th, 2017
Read More
Combinations, Biomarkers Will Be Future Focus in Metastatic NSCLC, Expert Says

August 18th, 2017
Read More
FDA Grants Alecensa Priority Review for Initial Treatment of People with ALK-Positive Lung Cancer

August 14th, 2017
Read More
8 brain tumor treatment questions, answered

August 9th, 2017
Read More
Does WBRT Still Have a Role for Cancer Patients With Brain Metastases?

July 17th, 2017
Read More
“A Nontoxic Pill May One Day Replace Chemotherapy, Researcher Says”

June 26th, 2017
Read More
Lung Cancer: FDA grants approval of ceritinib (Zykadia®) for ALK+ NSCLC

May 29th, 2017
Read More
Lung Cancer: FDA Grants Brigatinib Accelerated Approval for Metastatic Non-Small Cell Lung Cancer

May 24th, 2017
Read More
Lorlatinib, Granted Breakthrough Therapy Designation from FDA for ALK-Positive Metastatic NSCLC

May 1st, 2017
Read More
Our Founder and CEO, Matt Ellefson, talks to Forbes about NEW resource “Precision Medicine for Me.”

February 7th, 2017
Read More
More Immunotherapy Options Approved for Lung Cancer

November 26th, 2016
Read More
Keytruda - FDA Approval

October 26th, 2016
Read More
Video: Diagnostic testing for genetic mutations in lung cancer

September 16th, 2016
Read More